Sort
39,280 grants matching “leukemia”
Novel CART Cells for Treating AML
$493,002Xianxin Hua · University Of Pennsylvania · R01 · FY2024 · CA
A microfluidics-based paradigm for clinical lentivector gene transfer
$492,987Wilbur A Lam · Emory University · R01 · FY2019 · HL
Eeyarestatin I inhibits the p97 ATPase to induce tumor cell apoptosis
$492,938Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Developing a prediction model for vincristine-induced peripheral neuropathy
$492,849Jamie L Renbarger · Indiana University Indianapolis · RC1 · FY2009 · CA
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding
$492,841Lucas Ferrari De Andrade · Icahn School Of Medicine At Mount Sinai · R37 · FY2023 · CA
New control of oncogene activation in T-cell leukemia
$492,814Chengyu Liang · Wistar Institute · R01 · FY2024 · CA
Chromatin Insulators for Human Gene Therapy
$492,745George Stamatoyannopoulos · University Of Washington · P01 · FY2012 · HL
Pre-and Postgraduate Training in Molecular Hematology
$492,745Stephen Tracy Oh · Washington University · T32 · FY2021 · HL
Pre-BCR Function Selecting Novel B Cell Receptors in Chronic Lymphocytic Leukemia
$492,694Richard R Hardy · Research Inst Of Fox Chase Can Ctr · RC1 · FY2010 · CA
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology
$492,616Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2014 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2016 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2017 · HL
Analysis of Nematode Sex Determination
$492,581Barbara J Meyer · University Of California Berkeley · R01 · FY2006 · GM
Exploring the potential of TET inhibition in cancer immunotherapy
$492,576Anjana Rao · La Jolla Institute For Immunology · R01 · FY2022 · CA
Exploring the potential of TET inhibition in cancer immunotherapy
$492,576Anjana Rao · La Jolla Institute For Immunology · R01 · FY2023 · CA
Information flow through regulatory networks
$492,566Joseph David Coolon · Wesleyan University · R15 · FY2019 · GM
Human Decidual Leukocytes and Their Placental Ligands
$492,554Jack L Strominger · Harvard University · R01 · FY2010 · AI
Molecular and Cellular Immunology
$492,495Jason G. Cyster · University Of California, San Francisco · T32 · FY2018 · AI
Analysis of Nematode Sex Determination
$492,458Barbara J Meyer · University Of California Berkeley · R01 · FY2007 · GM
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
$492,410Fatih M Uckun · Children'S Hospital Of Los Angeles · U01 · FY2010 · CA
Mechanisms of enhancer regulation in leukemia
$492,409Iannis Aifantis · New York University School Of Medicine · R01 · FY2022 · CA
Mechanisms of enhancer regulation in leukemia
$492,409Iannis Aifantis · New York University School Of Medicine · R01 · FY2023 · CA
Virally-induced tumorigenesis controlled by the microbiota
$492,388Tatyana V. Golovkina · University Of Chicago · R01 · FY2019 · CA
Therapeutic targeting of growth factor receptors to treat Mucormycosis
$492,353Vincent Michael Bruno · University Of Maryland Baltimore · R01 · FY2023 · AI